Zisi Fotev Person-Info 

( Ich bin Zisi Fotev)

News

(1 - 4 von 8
)

atugen unterzeichnet Forschungsabkommen mit Roche

www.ots.at
— ... unserer Target Validation Technologie," sagte Dr. Zisi Fotev, Vice President Business Development der atugen Aktiengesellschaft. › amp › OTS_ _OTS0072

GeneBloc technology – Innovations Report

www.innovations-report.de
... regulated by an important cellular enzyme phosphatidyl-inositol 3-kinase" says Klaus Giese. Zisi Fotev | atugen AG Weitere Informationen:

Germany or Bust: US Biotechs Head East | IATP

www.iatp.org
Wall Street Journal | By Christopher Cooper, Staff Reporter of The Wall Street Journal
Dossier exportieren
+1